This information was published on 2026-03-10T11:00:55 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2489441 (IR 1693317) |
| (220) |
25 Sep 2024
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 1
Antibodies for scientific and research use; libraries of antibodies and collections of antibodies for scientific and research use; proteins, enzymes, diagnostic reagents, and chemical and biochemical preparations and substances for use in the manufacture of medicines. Class 5 Pharmaceutical preparations for T-Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer autoimmune diseases, and immunological disorders; chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposes, for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders. Class 44 Providing medical information about the treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders via a website. |
| (540) | LAVA THERAPEUTICS |
| (550) | Word |
| (730) |
Lava Therapeutics N.V.
|
Find out more about publications on the About page.